The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BGB-11417-203: An ongoing, phase 2 study of sonrotoclax (BGB-11417), a next-generation BCL2 inhibitor, in patients with Waldenström macroglobulinemia.
 
Hui-Peng Lee
Stock and Other Ownership Interests - CSL Behring (I)
Honoraria - Takeda
Consulting or Advisory Role - BeiGene
(OPTIONAL) Uncompensated Relationships - HSANZ
 
Stephen Opat
Honoraria - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Ipsen; Janssen; Merck; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Ipsen; Janssen; Merck; Novartis; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Gilead Sciences (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
Expert Testimony - Antengene
Travel, Accommodations, Expenses - EUSA Pharma
 
John Hrom
No Relationships to Disclose
 
David S. Kliman
No Relationships to Disclose
 
Paula Marlton
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Menarini; MSD; Novartis; Otsuka; Pfizer; SERVIER
Speakers' Bureau - Abbvie
 
Peng Liu
No Relationships to Disclose
 
Chenmu Du
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Amber Lussier
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jun Zhang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Haiyi Guo
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Steven P. Treon
Honoraria - Abbvie/Pharmacyclics; BeiGene; Janssen Oncology
Consulting or Advisory Role - Beigene; Janssen; Pharmacyclics
Research Funding - Abbvie (Inst); Beigene (Inst); Lilly (Inst); Pharmacyclics; X4 Pharma (Inst)
Patents, Royalties, Other Intellectual Property - my institution holds patents related to use of MYD88 and CXCR4 testing for which a predetermined financial distribution to the laboratory and individuals is provided. I have not received any income to this date related to these patents. (Inst)